Aalborg University and C4Pain, Aalborg, Denmark.
Arthritis Rheumatol. 2014 Dec;66(12):3317-26. doi: 10.1002/art.38856.
To assess the association between pain mechanisms (sensitization) and biochemical markers for cartilage, bone, and inflammation in patients with knee pain.
The study group comprised 281 patients with different degrees of knee pain intensity and radiographic findings (using the Kellgren/Lawrence [K/L] scale). The following structurally related serologic biomarkers were measured in serum: high-sensitivity C-reactive protein (hsCRP), matrix metalloproteinase (MMP)-mediated breakdown of CRP (CRPM), MMP-mediated degradation of type I collagen (C1M), C2M, and C3M. Pressure-pain thresholds (PPT) (peripheral and spreading sensitization), temporal summation of pain, and conditioning pain modulation (CPM) (with the latter 2 biomarkers representing generalized sensitization) were assessed. For each pain parameter, the patients were categorized as most sensitized or least sensitized.
Correlations were observed between the pain biomarkers PPT, temporal summation, and CPM and maximal pain intensity during the last 24 hours. Significant associations between most of the serologic biomarkers were observed. A high CRPM level was associated with centralized sensitization (temporal summation and CPM). None of the serologic markers correlated with the intensity or duration of knee pain, and only hsCRP correlated with the K/L grade. The most-sensitized group contained more women than men, and the least-sensitized group contained more men than women.
A platform of mechanistic pain biomarkers in combination with structure-related serologic biomarkers provides new possibilities for understanding how osteoarthritis-related structural features may be associated with pain and pain sensitization. This study showed significant correlations between central pain sensitization and CRPM as a possible measure for chronic inflammation. Future pain association studies should include biomarkers representing the local joint environment more specifically.
评估膝关节疼痛患者的疼痛机制(敏化)与软骨、骨和炎症的生化标志物之间的相关性。
研究组包括 281 名不同程度膝关节疼痛强度和影像学表现(使用 Kellgren/Lawrence [K/L] 分级)的患者。在血清中测量了以下与结构相关的血清生物标志物:高敏 C 反应蛋白(hsCRP)、基质金属蛋白酶(MMP)介导的 CRP 分解(CRPM)、MMP 介导的 I 型胶原降解(C1M)、C2M 和 C3M。评估了压力疼痛阈值(PPT)(周围和扩散敏化)、疼痛时间总和和条件疼痛调制(CPM)(后两者标志物代表广义敏化)。对于每个疼痛参数,患者分为最敏感或最不敏感。
观察到疼痛生物标志物 PPT、时间总和和 CPM 与过去 24 小时内的最大疼痛强度之间存在相关性。观察到大多数血清生物标志物之间存在显著相关性。高 CRPM 水平与集中敏化(时间总和和 CPM)相关。没有任何血清标志物与膝关节疼痛的强度或持续时间相关,只有 hsCRP 与 K/L 分级相关。最敏感组中女性多于男性,而最不敏感组中男性多于女性。
机械性疼痛生物标志物与结构相关血清生物标志物的平台为理解骨关节炎相关结构特征如何与疼痛和疼痛敏化相关提供了新的可能性。本研究显示,中央疼痛敏化与 CRPM 之间存在显著相关性,CRPM 可能是慢性炎症的一种衡量标准。未来的疼痛关联研究应更具体地包括代表局部关节环境的生物标志物。